---
layout: default
title: Publications
---

<center><a href="https://scholar.google.com/citations?user=SpJNsxYAAAAJ&hl=en"><img src="/images/google-scholar-icon.png" alt="https://scholar.google.com/citations?user=SpJNsxYAAAAJ&hl=en" title="https://scholar.google.com/citations?user=SpJNsxYAAAAJ&hl=en" width="50" height="50" /></a>
<a href="https://orcid.org/0000-0003-1297-6337"><img src="/images/orcid-icon.png" alt="https://orcid.org/0000-0003-1297-6337" title="https://orcid.org/0000-0003-1297-6337" width="50" height="50" /></a>
<a href="https://www.researchgate.net/profile/Brittany_Boribong"><img src="/images/researchgate-icon.png" alt="https://www.researchgate.net/profile/Brittany_Boribong" title="https://www.researchgate.net/profile/Brittany_Boribong" width="50" height="50" /></a>
</center>

<span style="font-size:1.2em">
**19.** Tang Y\*, **Boribong BP**\*, Swank ZN, Demokritou M, Luban MAF, Fasano A, Du M, Wolf RL, Griffiths J, Shultz J, Borberg E, Chalise S, Gonzalez WI, Walt DR, Yonker LM, \& Horwitz BH.  (2024). **COVID-19 mRNA Vaccines Induce Robust Levels of IgG but Limited Amounts of IgA Within the Oronasopharynx of Young Children**. *The Journal of Infectious Diseases*. 
[https://doi.org/10.1093/infdis/jiae450](https://doi.org/10.1093/infdis/jiae450) \*denotes equal contribution
</span>
<br>

<span style="font-size:1.2em">
**18.** Philpott JD, Miller J, **Boribong BP**, Charles S, Davis JP, Kazimierczyk S, Jimena B, Leonard MM, Shreffler WG, Fasano A, Yonker LM, & Jain N. (2023). **Antigen-specific T cell responses in SARS-CoV-2 mRNA-vaccinated children**. *Cell Reports Medicine*. 
[https://doi.org/10.1016/j.xcrm.2023.101298](https://doi.org/10.1016/j.xcrm.2023.101298)
</span>
<br>

<span style="font-size:1.2em">
**17.** Proal AD, VanElzakker MB, Aleman S, Bach K, **Boribong BP**, Buggert M, Cherry S, Chertow DS, Davies HE, Dupont CL, Deeks SG, Eimer W, Ely EW, Fasano A, Freire M, Geng LN, Griffin DE, Henrich TJ, Iwasaki A, Izquierdo-Garcia D, Locci M, Mehandru S, Painter MM, Peluso MJ, Pretorius E, Price DA, Putrino D, Scheuermann RH, Tan GS, Tanzi RE, VanBrocklin HF, Yonker LM, & Wherry EJ.. (2023). *SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)**. *Nature Immunology*. [https://doi.org/10.1038/s41590-023-01601](https://doi.org/10.1038/s41590-023-01601)
</span>
<br>

<span style="font-size:1.2em">
**16.** Kane AS, **Boribong BP**, Loiselle M, Chitnis AP, Chavez H, Moldawer LL, Larson SD, Badaki-Makun O, Irimia D, & Yonker LM. (2023). **Monocyte anisocytosis corresponds with increasing severity of COVID-19 in children**. *Frontiers in Pediatrics*. [https://doi.org/10.3389/fped.2023.1177048](https://doi.org/10.3389/fped.2023.1177048)
</span>
<br>

<span style="font-size:1.2em">
**15.** Burns MD, Bartsch YC, Davis JP, **Boribong BP**, Loiselle M, Kang J, Kane AS, Edlow AG, Fasano A, Alter G, & Yonker LM.  (2023). **Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children**. *Pediatric Research*. [https://doi.org/10.1038/s41390-023-02627-w](https://doi.org/10.1038/s41390-023-02627-w)
</span>
<br>

<span style="font-size:1.2em">
**14.** Yonker LM, Swank Z, Bartsch YC, Burns MD, Kane A, **Boribong BP**, Davis JP, Losielle M, Novak T, Senussi Y, Cheng CA, Burgess E, Edlow AG, Chou J, Dionne A, Balaguru D, Lahoud-Rahme M, Arditi M, Julg B, Randolph AG, Alter G, Fasano A, & Walt DR. (2023). **Circulating Spike Protein Detected in Postâ€“COVID-19 mRNA Vaccine Myocarditis**. *Circulation*. [https://doi.org/10.1161/CIRCULATIONAHA.122.061025](https://doi.org/10.1161/CIRCULATIONAHA.122.061025)
</span>
<br>

<span style="font-size:1.2em">
**13.** **Boribong BP**\*, LaSalle TJ\*, Bartsch YC, Ellett F, Loiselle ME, Davis JP, Gonye ALK, Sykes DB, Hajizadeh S, Kreuzer J, Pillai S, Haas W, Edlow AG, Fasano A, Alter G, Irimia D, Sade-Feldman M, & Yonker LM. (2022). **Neutrophil Profiles of Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children**. *Cell Reports Medicine*. [https://doi.org/10.1016/j.xcrm.2022.100848](https://doi.org/10.1016/j.xcrm.2022.100848) \*denotes equal contribution
</span>
<br>

<span style="font-size:1.2em">
**12.** Bartsch YC, St Dennis KJ, Kaplonek P, Kang J, Lam EC, Burns MD, Farkas EJ, Davis JP, **Boribong BP**, Edlow AG, Fasano A, Shreffler W, Zavadska D, Johnson M, Goldblatt D, Balazs AB, Yonker LM, & Alter G. (2022). **SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children**. *Science Translational Medicine*, eabn9237. [https://doi.org/10.1126/scitranslmed.abn9237](https://doi.org/10.1126/scitranslmed.abn9237)
</span>
<br>

<span style="font-size:1.2em">
**11.** Yonker LM, Badaki-Makun O, Puneeta A, **Boribong BP**, Moraru G, Fenner B, Rincon J, Hopke A, Rogers B, Hinson J, Fasano A, Lee L, Kehoe SM, Larson SD, Chavez H, Levin S, Moldawer LL, & Irimia D. (2022). **Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications**. *BMC Infectious Disease*, 22(1), 1-11. [https://doi.org/10.1186/s12879-022-07526-9](https://doi.org/10.1186/s12879-022-07526-9)
</span>
<br>

<span style="font-size:1.2em">
**10.** Burns MD\*, **Boribong BP**\*, Bartsch YC, Loiselle ME, St. Denis KJ, Sheehan ML, Chen JW, Davis JP, Lima R, Edlow AG, Fasano A, Balazs AB, Alter G, & Yonker LM. (2022). **Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children**. *Vaccines*, 10(4), 492. [https://doi.org/10.3390/vaccines10040492](https://doi.org/10.3390/vaccines10040492) \*denotes equal contribution
</span>
<br>
 
<span style="font-size:1.2em">
**9.** Silverstein NJ, Wang Y, Manickas-Hill Z, Carbone C, Dauphin A, **Boribong BP**, Loiselle ME, Davis JP, Leonard MM, Kuri-Cervantes L, MGH COVID-19 Collection & Processing Team, Meyer NJ, Betts MR, Li JZ, Walker BD, Xu GY, Yonker LM, & Luban J. (2022). **Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection**. *eLife*, 11, e74681. [https://doi.org/10.7554/eLife.74681](https://doi.org/10.7554/eLife.74681)
</span>
<br>
  
<span style="font-size:1.2em">
**8.** Yonker LM, Swank Z, Gilboa T, Senussi Y, Kenyon V, Papadakis L, **Boribong BP**, Carroll RW, Walt DR, & Fasano A. (2022). **Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series**. *Critical Care Explorations*, 10, 2. [https://dx.doi.org/10.1097%2FCCE.0000000000000641](https://dx.doi.org/10.1097%2FCCE.0000000000000641)
</span>
<br>
  
<span style="font-size:1.2em">
**7.** **Boribong BP**, Puneeta A, & Yonker LM. (2021). **The Heart of the Problem in Multisystem Inflammatory Syndrome in Children**. *Med*, 2, 9. [https://doi.org/10.1016/j.medj.2021.08.008](https://doi.org/10.1016/j.medj.2021.08.008)

  
<span style="font-size:1.2em">
**6.** Yonker LM, Gilboa T, Ogata AF, Senussi Y, Lazarovits R, **Boribong BP**, Bartsch YC, Loiselle ME, Rivas MN, Porritt RA, Lima R, Davis JP, Farkas EJ, Burns MD, Young N, Mahajan VS, Hajizadeh S, Herrera Lopez XI, Kreuzer J, Morris R, Martinez EE, Han I, Griswold Jr. K, Barry NC, Thompson DB, Church G, Edlow AG, Haas W, Pillai S, Arditi M, Alter G, Walt DR, & Fasano A. (2021). **Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier**. *The Journal of Clinical Investigation*, 131(14):e149633. [https://doi.org/10.1172/JCI149633](https://doi.org/10.1172/JCI149633)
</span>
<br>
  
<span style="font-size:1.2em">
**5.** Davis MM, Brock AM, DeHart TG, **Boribong BP**, Lee K, McClune ME, Chang Y, Cramer N, Liu J, Jones CN, & Jutras BL. (2021). **The peptidoglycan-associated protein NapA plays an important role in the envelope integrity and in the pathogenesis of the lyme disease spirochete**. *PloS Pathogens*, 17, 5. [https://doi.org/10.1371/journal.ppat.1009546](https://doi.org/10.1371/journal.ppat.1009546)
</span>
<br>
  
<span style="font-size:1.2em">
**4.** Ciupe SM, **Boribong BP**, Kadelka S, & Jones CN. (2021). **Bistable mathematical model of neutrophil migratory patterns after LPS-induced epigenetic reprogramming**. *Frontiers in Genetics*, 12, 172. [https://doi.org/10.3389/fgene.2021.633963](https://doi.org/10.3389/fgene.2021.633963)
</span>
<br>
  
<span style="font-size:1.2em">
**3.** **Boribong, BP**, Lenzi, MJ, Li, L, & Jones, CN. (2019). **Super-low dose lipopolysaccharide dysregulates neutrophil migratory decision-making**. *Frontiers in Immunology*, 10, 359. [https://doi.org/10.3389/fimmu.2019.00359](https://doi.org/10.3389/fimmu.2019.00359)
</span>
<br>
  
<span style="font-size:1.2em">
**2.** **Boribong, BP**, Rahimi, A, & Jones, CN. (2019). **Microfluidic Platform to Quantify Neutrophil Migratory Decision-Making**. In *Mouse Models of Innate Immunity* (pp. 113-122). Humana Press, New York, NY. [https://doi.org/10.1007/978-1-4939-9167-9_10](https://doi.org/10.1007/978-1-4939-9167-9_10)
</span>
<br>
  
<span style="font-size:1.2em">
**1.** Kadelka, S, **Boribong, BP**, Li, L, & Ciupe, SM. (2019). **Modeling the Bistable Dynamics of the Innate Immune System**. *Bulletin of Mathematical Biology*, 81(1), 256-276. [https://doi.org/10.1007/s11538-018-0527-y](https://doi.org/10.1007/s11538-018-0527-y)
</span>
